CONMED (CNMD) Competitors

Stevanato Group (NYSE:STVN) and CONMED (NYSE:CNMD) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking.

Which has more volatility & risk, STVN or CNMD?

Stevanato Group has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.

Does the MarketBeat Community believe in STVN or CNMD?

CONMED received 6 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 62.50% of users gave Stevanato Group an outperform vote while only 47.37% of users gave CONMED an outperform vote.

Company	Underperform	Outperform
Stevanato Group	Outperform Votes 30 62.50%	Underperform Votes 18 37.50%
CONMED	Outperform Votes 36 47.37%	Underperform Votes 40 52.63%

Is STVN or CNMD a better dividend stock?

Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.3%. CONMED pays an annual dividend of $0.80 per share and has a dividend yield of 1.6%. Stevanato Group pays out 12.5% of its earnings in the form of a dividend. CONMED pays out 18.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Which has higher earnings and valuation, STVN or CNMD?

Stevanato Group has higher earnings, but lower revenue than CONMED. CONMED is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	$1.10B	6.18	$157.62M	$0.48	46.96
CONMED	$1.31B	1.15	$132.42M	$4.24	11.44

Is STVN or CNMD more profitable?

Stevanato Group has a net margin of 10.47% compared to CONMED's net margin of 10.13%. CONMED's return on equity of 14.31% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	10.47%	9.86%	5.79%
CONMED	10.13%	14.31%	5.64%

Do analysts rate STVN or CNMD?

CONMED has a consensus price target of $77.20, suggesting a potential upside of 59.21%. Given CONMED's higher probable upside, analysts clearly believe CONMED is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
CONMED	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Does the media favor STVN or CNMD?

In the previous week, Stevanato Group and Stevanato Group both had 5 articles in the media. Stevanato Group's average media sentiment score of 1.22 beat CONMED's score of 0.85 indicating that Stevanato Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Stevanato Group beats CONMED on 10 of the 17 factors compared between the two stocks.